Plant ID: NPO13017
Plant Latin Name: Sarcocephalus Latifolius
Taxonomy Genus: Sarcocephalus
Taxonomy Family: Rubiaceae
NCBI TaxonomyDB:
43573
Plant-of-the-World-Online:
n.a.
Ingredient ID: NPC99964
Ingredient ID: NPC99006
Ingredient ID: NPC98175
Ingredient ID: NPC96337
Ingredient ID: NPC93194
Ingredient ID: NPC91972
Ingredient ID: NPC88603
Ingredient ID: NPC85637
Ingredient ID: NPC82287
Ingredient ID: NPC80692
Ingredient ID: NPC77579
Ingredient ID: NPC75247
Ingredient ID: NPC74758
Ingredient ID: NPC73489
Ingredient ID: NPC72237
Ingredient ID: NPC68173
Ingredient ID: NPC67532
Ingredient ID: NPC61305
Ingredient ID: NPC61057
Ingredient ID: NPC58959
Ingredient ID: NPC58809
Ingredient ID: NPC55154
Ingredient ID: NPC54199
Ingredient ID: NPC53449
Ingredient ID: NPC52620
Ingredient ID: NPC51920
Ingredient ID: NPC51694
Ingredient ID: NPC49327
Ingredient ID: NPC484195
Ingredient ID: NPC484194
Ingredient ID: NPC484193
Ingredient ID: NPC484192
Ingredient ID: NPC484191
Ingredient ID: NPC484190
Ingredient ID: NPC42150
Ingredient ID: NPC311969
Ingredient ID: NPC307021
Ingredient ID: NPC306551
Ingredient ID: NPC306009
Ingredient ID: NPC305642
Ingredient ID: NPC304373
Ingredient ID: NPC3031
Ingredient ID: NPC301983
Ingredient ID: NPC298934
Ingredient ID: NPC298509
Ingredient ID: NPC297084
Ingredient ID: NPC295534
Ingredient ID: NPC293804
Ingredient ID: NPC292265
Ingredient ID: NPC292090
Ingredient ID: NPC291186
Ingredient ID: NPC289642
Ingredient ID: NPC286188
Ingredient ID: NPC28583
Ingredient ID: NPC282999
Ingredient ID: NPC280452
Ingredient ID: NPC27744
Ingredient ID: NPC275846
Ingredient ID: NPC273757
Ingredient ID: NPC272256
Ingredient ID: NPC267068
Ingredient ID: NPC260507
Ingredient ID: NPC255467
Ingredient ID: NPC255076
Ingredient ID: NPC255042
Ingredient ID: NPC255027
Ingredient ID: NPC253679
Ingredient ID: NPC253301
Ingredient ID: NPC25317
Ingredient ID: NPC251097
Ingredient ID: NPC251031
Ingredient ID: NPC250563
Ingredient ID: NPC247380
Ingredient ID: NPC246096
Ingredient ID: NPC245419
Ingredient ID: NPC242631
Ingredient ID: NPC239242
Ingredient ID: NPC234424
Ingredient ID: NPC231276
Ingredient ID: NPC230960
Ingredient ID: NPC225136
Ingredient ID: NPC220140
Ingredient ID: NPC218298
Ingredient ID: NPC21078
Ingredient ID: NPC210480
Ingredient ID: NPC209575
Ingredient ID: NPC208485
Ingredient ID: NPC202369
Ingredient ID: NPC199623
Ingredient ID: NPC198272
Ingredient ID: NPC197059
Ingredient ID: NPC196733
Ingredient ID: NPC196333
Ingredient ID: NPC195624
Ingredient ID: NPC195287
Ingredient ID: NPC194465
Ingredient ID: NPC194456
Ingredient ID: NPC189840
Ingredient ID: NPC187217
Ingredient ID: NPC184203
Ingredient ID: NPC18215
Ingredient ID: NPC18205
Ingredient ID: NPC179650
Ingredient ID: NPC178799
Ingredient ID: NPC178152
Ingredient ID: NPC174525
Ingredient ID: NPC174406
Ingredient ID: NPC173721
Ingredient ID: NPC173305
Ingredient ID: NPC172112
Ingredient ID: NPC172093
Ingredient ID: NPC164646
Ingredient ID: NPC164498
Ingredient ID: NPC161496
Ingredient ID: NPC160468
Ingredient ID: NPC158059
Ingredient ID: NPC157538
Ingredient ID: NPC15707
Ingredient ID: NPC156461
Ingredient ID: NPC156018
Ingredient ID: NPC145154
Ingredient ID: NPC144916
Ingredient ID: NPC142438
Ingredient ID: NPC140857
Ingredient ID: NPC137739
Ingredient ID: NPC137136
Ingredient ID: NPC130278
Ingredient ID: NPC126998
Ingredient ID: NPC121958
Ingredient ID: NPC119250
Ingredient ID: NPC116517
Ingredient ID: NPC115448
Ingredient ID: NPC10781
Ingredient ID: NPC103560
Ingredient ID: NPC10151
Ingredient ID: NPC101079
Ingredient ID: NPC100135
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Small molecule receptor (family A GPCR) | ADORA1 | Adenosine A1 receptor | P30542 | CHEMBL226 |
Therapeutic Target | Small molecule receptor (family A GPCR) | ADORA2A | Adenosine A2a receptor | P29274 | CHEMBL251 |
Therapeutic Target | Small molecule receptor (family A GPCR) | ADORA3 | Adenosine A3 receptor | P0DMS8 | CHEMBL256 |
Therapeutic Target | Transient receptor potential channel | TRPA1 | Transient receptor potential cation channel subfamily A member 1 | O75762 | CHEMBL6007 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 152 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT00481689 | Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT02511561 | OTO-201 for the Treatment of Otitis Externa | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT00598403 | Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT01932112 | Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial) | atrial fibrillation | Adenosine (NPC156461) | NP level |
NCT01108601 | Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity | hearing loss | Ciprofloxacin (NPC292265) | NP level |
NCT02357407 | Development of an Adjustment Assistance Tool Dosage of Fluoroquinolones in a Population Pharmacokinetic Model | infection | Ciprofloxacin (NPC292265) | NP level |
NCT00609973 | Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease | Crohn's disease | Ciprofloxacin (NPC292265) | NP level |
NCT03354598 | Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT01764841 | Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) | Bronchiectasis | Ciprofloxacin (NPC292265) | NP level |
NCT03032965 | Adenosine to Assess Complete Conduction Block During Catheter Ablation of Paroxysmal Atrial Fibrillation | atrial fibrillation | Adenosine (NPC156461) | NP level |
NCT00961675 | FST-201 in the Treatment of Acute Otitis Externa | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT00809913 | Febrile Urinary Tract Infection Randomized Short Treatment Trial | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT04523987 | A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. | pancreatic ductal adenocarcinoma | Ciprofloxacin (NPC292265) | NP level |
NCT04879030 | Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD | chronic obstructive pulmonary disease | Ciprofloxacin (NPC292265) | NP level |
NCT00781404 | Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI | acute myocardial infarction | Adenosine (NPC156461) | NP level |
NCT00791505 | Antibiotic/COPD in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) Requiring Mechanical Ventilation | Sepsis | Ciprofloxacin (NPC292265) | NP level |
NCT00872209 | Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT05442736 | Modified Surface of PLGA Nanoparticles in Smart Hydrogel | infection | Ciprofloxacin (NPC292265) | NP level |
NCT02867878 | Adenosin to Rapidly Reverse Left Ventricle Impairment in Takotsubo Syndrome | Takotsubo cardiomyopathy | Adenosine (NPC156461) | NP level |
NCT01279252 | CLL Empirical Antibiotic Regimen | chronic lymphocytic leukemia | Ciprofloxacin (NPC292265) | NP level |
NCT01952444 | Safety, Tolerability and PK of Intravenous (IV) ETI-204 Alone and in Presence of Ciprofloxacin in Adult Volunteers | anthrax infection | Ciprofloxacin (NPC292265) | NP level |
NCT03862170 | Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer | prostate cancer | Ciprofloxacin (NPC292265) | NP level |
NCT03969758 | Ciprofloxacin Plus Metronidazole Vs Cefixime Plus Metronidazole Therapy for the Treatment of Liver Abscess | Liver abscess | Ciprofloxacin (NPC292265) | NP level |
NCT05014061 | Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction | Myocardial Ischemia | Adenosine (NPC156461) | NP level |
NCT01659866 | Antibiotic Prophylaxis for Transrectal Prostate Biopsy | infection | Ciprofloxacin (NPC292265) | NP level |
NCT00761462 | BAY 0 9867 Cipro Pediatric Use Study (QUIP) | infectious disease | Ciprofloxacin (NPC292265) | NP level |
NCT01994642 | Bioequivalence of Two Ciprofloxacin 0.3%/Dexamethasone 0.1% Sterile Otic Suspensions in Otitis Media in Children With Tympanostomy Tubes | Otitis media | Ciprofloxacin (NPC292265) | NP level |
NCT00654108 | Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects | gastroenteritis | Ciprofloxacin (NPC292265) | NP level |
NCT03357614 | Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT04165850 | Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS | amyotrophic lateral sclerosis | Ciprofloxacin (NPC292265) | NP level |
NCT01910155 | A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT02801370 | Phase 3 Study of OTO-201 in Acute Otitis Externa | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT04666454 | BROKEN-SWEDEHEART-Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome | Takotsubo cardiomyopathy | Adenosine (NPC156461) | NP level |
NCT02216071 | Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT00663806 | A Phase IV Study of Cipro XR in Uncomplicated UTI | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT00980876 | A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT04090684 | Ciprofloxacin/Celecoxib Combination in Patients With ALS | amyotrophic lateral sclerosis | Ciprofloxacin (NPC292265) | NP level |
NCT02505581 | Parenteral Antibiotics Compared to Combination of Oral and Parenteral Antibiotics in Colorectal Surgery Prophylaxis | infection | Ciprofloxacin (NPC292265) | NP level |
NCT05199324 | Early Oral Step-down Antibiotic Therapy for Uncomplicated Gram-negative Bacteraemia | bacteriemia | Ciprofloxacin (NPC292265) | NP level |
NCT01157819 | Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT04204954 | Evaluation of Treatment Option for Demodicosis in Patients Undergoing Cataract Surgery | cataract | Ciprofloxacin (NPC292265) | NP level |
NCT02015507 | An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor | cystic fibrosis | Ciprofloxacin (NPC292265) | NP level |
NCT00138411 | Monoclonal Antibody for Treatment of Inhalation Anthrax | anthrax infection | Ciprofloxacin (NPC292265) | NP level |
NCT03326050 | Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma | rhinoscleroma | Ciprofloxacin (NPC292265) | NP level |
NCT01211561 | Colon Cancer Prevention Using Selenium | colorectal adenocarcinoma | Selenomethionine (NPC291186) | NP level |
NCT02302768 | Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT | Hashimoto's thyroiditis | Selenomethionine (NPC291186) | NP level |
NCT01595438 | Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) | pyelonephritis | Ciprofloxacin (NPC292265) | NP level |
NCT05462496 | Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer | pancreatic carcinoma | Ciprofloxacin (NPC292265) | NP level |
NCT01749605 | A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT00961038 | Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | chronic obstructive pulmonary disease | Ciprofloxacin (NPC292265) | NP level |
NCT02600559 | Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes | Otitis media | Ciprofloxacin (NPC292265) | NP level |
NCT00676533 | Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT01497431 | Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants | prostate carcinoma | (2R)-2-Amino-3-Methylselanylpropanoic Acid (NPC53449) | NP level |
NCT00107081 | Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting | Fever;neutropenia | Ciprofloxacin (NPC292265) | NP level |
NCT04636957 | A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE) | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT04870138 | Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial) | infection | Ciprofloxacin (NPC292265) | NP level |
NCT00930982 | Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis | Bronchiectasis | Ciprofloxacin (NPC292265) | NP level |
NCT00845689 | Prevention of Liver Damage During Liver Surgery | neoplasm | Adenosine (NPC156461) | NP level |
NCT05431673 | Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma | rhinoscleroma | Ciprofloxacin (NPC292265) | NP level |
NCT04549311 | Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial | abscess | Ciprofloxacin (NPC292265) | NP level |
NCT00714103 | 8-Chloro-Adenosine in Chronic Lymphocytic Leukemia | chronic lymphocytic leukemia | Adenosine (NPC156461) | NP level |
NCT01561794 | A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia | pneumonia | Ciprofloxacin (NPC292265) | NP level |
NCT03236311 | A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI | coronary artery disease | Adenosine (NPC156461) | NP level |
NCT00964561 | Ph1 Study of Valortim and Ciprofloxacin in Humans | anthrax infection | Ciprofloxacin (NPC292265) | NP level |
NCT00003824 | S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer | urinary bladder cancer | Ciprofloxacin (NPC292265) | NP level |
NCT00257699 | Study of Antibiotics in the Treatment of Colonic Crohn's Disease | Crohn's disease | Ciprofloxacin (NPC292265) | NP level |
NCT02532192 | A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma | lymphoma | Ciprofloxacin (NPC292265) | NP level |
NCT01873690 | Efficacy of Antimicrobial Prophylaxis for Shock Wave Lithotripsy (SWL) on Reducing Urinary Tract Infection (UTI) | urolithiasis | Ciprofloxacin (NPC292265) | NP level |
NCT00722735 | Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI) | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT00126698 | Prophylactic Antibiotics on Urethral Catheter Withdrawal | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT00625183 | Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma | colorectal carcinoma | Selenomethionine (NPC291186) | NP level |
NCT00736645 | Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | prostate cancer | Selenomethionine (NPC291186) | NP level |
NCT00142272 | Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial | gastrointestinal disease | Ciprofloxacin (NPC292265) | NP level |
NCT02130713 | Treatment of Chronic Bacterial Prostatitis | prostatitis | Ciprofloxacin (NPC292265) | NP level |
NCT02620007 | Evaluation of Adherent Invasive E. Coli Eradication in Adult Crohn Disease | Crohn's disease | Ciprofloxacin (NPC292265) | NP level |
NCT01359098 | Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT01908803 | Proof-of-Concept Study of a Single Application of an Investigational Otic Suspension in Treatment of Acute Otitis Media With Tympanostomy Tubes | Otitis media | Ciprofloxacin (NPC292265) | NP level |
NCT00455416 | Dietary Intervention in Follicular Lymphoma | follicular lymphoma | Selenomethionine (NPC291186) | NP level |
NCT00030901 | S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate | prostate cancer | Selenomethionine (NPC291186) | NP level |
NCT03476317 | Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease | Crohn's disease | Ciprofloxacin (NPC292265) | NP level |
NCT00284323 | Salvage: Postconditioning With Adenosine for STEMI | ST Elevation Myocardial Infarction | Adenosine (NPC156461) | NP level |
NCT01803191 | Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT02719158 | Dose Ranging Study of OTO-201 in AOMT | Otitis media | Ciprofloxacin (NPC292265) | NP level |
NCT00179010 | AMP as a Better Delivery System of Adenosine | ischemia | Adenosine (NPC156461) | NP level |
NCT01505634 | Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003) | pyelonephritis | Ciprofloxacin (NPC292265) | NP level |
NCT05363631 | Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab | clear cell renal carcinoma | Selenomethionine (NPC291186) | NP level |
NCT04392362 | A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT) | ventricular tachycardia | Adenosine (NPC156461) | NP level |
NCT00669994 | Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT01233492 | Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme | Central Nervous System Neoplasm | L-Phenylalanine (NPC10781) | NP level |
NCT01593644 | Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler | coronary artery disease | Adenosine (NPC156461) | NP level |
NCT00002850 | Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy | infection | Ciprofloxacin (NPC292265) | NP level |
NCT01757236 | Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection | infection | Ciprofloxacin (NPC292265) | NP level |
NCT02598362 | Pharmacokinetics of Ciprofloxacin in Pediatric Patients | pyelonephritis | Ciprofloxacin (NPC292265) | NP level |
NCT01072942 | To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III) | chronic obstructive pulmonary disease | Ciprofloxacin (NPC292265) | NP level |
NCT00751491 | Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI) | angina pectoris | Adenosine (NPC156461) | NP level |
NCT04552431 | Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and Tamsulosin | prostatitis | Ciprofloxacin (NPC292265) | NP level |
NCT02300220 | Targeted Retreatment of COPD Exacerbations | chronic obstructive pulmonary disease | Ciprofloxacin (NPC292265) | NP level |
NCT00688272 | Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag | autoimmune thrombocytopenic purpura | Ciprofloxacin (NPC292265) | NP level |
NCT00645788 | Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis | cystic fibrosis | Ciprofloxacin (NPC292265) | NP level |
NCT00889967 | Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1" | Bronchiectasis | Ciprofloxacin (NPC292265) | NP level |
NCT01690884 | Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake | coronary artery disease | Adenosine (NPC156461) | NP level |
NCT01928433 | Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis | pyelonephritis | Ciprofloxacin (NPC292265) | NP level |
NCT01789203 | Ciprofloxacin for Prevention of BK Infection | infection | Ciprofloxacin (NPC292265) | NP level |
NCT02681913 | Adenosine as an Adjunct to Blood Cardioplegia | cardiomyopathy | Adenosine (NPC156461) | NP level |
NCT01123525 | Adenosine Cardioplegia | angina pectoris | Adenosine (NPC156461) | NP level |
NCT01515007 | Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3) | Bronchiectasis | Ciprofloxacin (NPC292265) | NP level |
NCT00829205 | Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | lymphoma | (2R)-2-Amino-3-Methylselanylpropanoic Acid (NPC53449) | NP level |
NCT01052298 | Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) | lung disease | Ciprofloxacin (NPC292265) | NP level |
NCT00741052 | Ciprofloxacin Multiple Dose for Adult Cholera | gastrointestinal disease | Ciprofloxacin (NPC292265) | NP level |
NCT01243437 | A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans | Yersinia pestis infectious disease | Ciprofloxacin (NPC292265) | NP level |
NCT02099240 | Patients Response to Early Switch To Oral:Osteomyelitis Study | osteomyelitis | Ciprofloxacin (NPC292265) | NP level |
NCT05162625 | Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial | endophthalmitis | Ciprofloxacin (NPC292265) | NP level |
NCT02947763 | Single Versus Multiple Visits Endodontic Treatment | Periapical Periodontitis | Ciprofloxacin (NPC292265) | NP level |
NCT01124799 | TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light | hepatitis C virus infection | Ciprofloxacin (NPC292265) | NP level |
NCT00565188 | Application of ATP Infusions in Palliative Home Care | cancer | Adenosine (NPC156461) | NP level |
NCT00945802 | FST-201 In The Treatment of Acute Otitis Externa | otitis externa | Ciprofloxacin (NPC292265) | NP level |
NCT03840811 | Experimental Human Infection With Neisseria Gonorrhoeae | infection | Ciprofloxacin (NPC292265) | NP level |
NCT00910351 | Cipro Inhaler for Cystic Fibrosis Children Ages 6-12 | Pseudomonas infection | Ciprofloxacin (NPC292265) | NP level |
NCT00590785 | Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) | breast cancer | Ciprofloxacin (NPC292265) | NP level |
NCT00736164 | Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer | prostate cancer | Selenomethionine (NPC291186) | NP level |
NCT00298636 | Dose-Response of Adenosine for Perioperative Pain | pain | Adenosine (NPC156461) | NP level |
NCT03358576 | Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI) | infection | Ciprofloxacin (NPC292265) | NP level |
NCT01768663 | A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects | cystic fibrosis | Ciprofloxacin (NPC292265) | NP level |
NCT01756924 | Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection | infection | Ciprofloxacin (NPC292265) | NP level |
NCT02104245 | Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) | Bronchiectasis | Ciprofloxacin (NPC292265) | NP level |
NCT01783106 | Antibiotics and Hydroxychloroquine in Crohn's | Crohn's disease | Ciprofloxacin (NPC292265) | NP level |
NCT02773732 | Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101) | acute myeloid leukemia | Ciprofloxacin (NPC292265) | NP level |
NCT02765256 | Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease | Crohn's disease | Ciprofloxacin (NPC292265) | NP level |
NCT01599806 | Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections) | pyelonephritis | Ciprofloxacin (NPC292265) | NP level |
NCT00526890 | Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | lung cancer | Selenomethionine (NPC291186) | NP level |
NCT01753115 | Ciprofloxacin BioThrax Co-Administration Study | anthrax infection | Ciprofloxacin (NPC292265) | NP level |
NCT00668122 | Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections | urinary tract infection | Ciprofloxacin (NPC292265) | NP level |
NCT02011841 | Rifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic Patients | peritonitis | Ciprofloxacin (NPC292265) | NP level |
NCT04588441 | The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19 | acute respiratory distress syndrome | Adenosine (NPC156461) | NP level |
NCT05294588 | Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae | gonorrhea | Ciprofloxacin (NPC292265) | NP level |
NCT03150082 | Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects | infection | Ciprofloxacin (NPC292265) | NP level |
NCT02106832 | Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) | Bronchiectasis | Ciprofloxacin (NPC292265) | NP level |
NCT02036528 | Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers | diabetic foot | Ciprofloxacin (NPC292265) | NP level |
NCT01208922 | Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea | Diarrhea | Ciprofloxacin (NPC292265) | NP level |
NCT02734732 | Antibiotic Prophylaxis for Transrectal Prostate Biopsy-Ciprofloxacin vs. Trimethoprim/Sulfamethoxazole | infection | Ciprofloxacin (NPC292265) | NP level |
NCT00294749 | Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy | prostate cancer | Ciprofloxacin (NPC292265) | NP level |
NCT00580905 | Role of Adenosine in the Release of VEGF and Cytokines | inflammation | Adenosine (NPC156461) | NP level |
NCT00349921 | Clonidine Versus Adenosine to Treat Neuropathic Pain | pain | Adenosine (NPC156461) | NP level |
NCT00004216 | VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy | neoplasm | Ciprofloxacin (NPC292265) | NP level |
NCT00670215 | BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis | bacterial disease | Ciprofloxacin (NPC292265) | NP level |
NCT01747174 | REperfusion Facilitated by LOcal Adjunctive Therapy in ST-elevation Myocardial Infarction | ST Elevation Myocardial Infarction | Adenosine (NPC156461) | NP level |
NCT03177720 | Evaluation of Innovative Tools in Development of Antibiotics | pneumonia | Ciprofloxacin (NPC292265) | NP level |
NCT00612521 | Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis | coronary stenosis | Adenosine (NPC156461) | NP level |
NCT00590070 | THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction | myocardial infarction | Adenosine (NPC156461) | NP level |
NCT02535533 | SLM + Axitinib for Clear Cell RCC | clear cell renal carcinoma | Selenomethionine (NPC291186) | NP level |
NCT02326103 | Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis | alcoholic liver cirrhosis;Hepatitis, Alcoholic | Ciprofloxacin (NPC292265) | NP level |
NCT04952129 | Optimal Selenium for Bowel Polyps (OSCAR) | colorectal adenoma | (2R)-2-Amino-3-Methylselanylpropanoic Acid (NPC53449);Selenomethionine (NPC291186) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
ADORA2A
NCT00294749,NCT03862170,NCT00736645,NCT00736164,NCT00030901 |
BronchiectasisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA24 |
NCT01515007,NCT01764841,NCT02106832,NCT00930982,NCT02104245,NCT00889967
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
NCT02765256,NCT00609973,NCT02620007,NCT03476317,NCT00257699,NCT01783106
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
TOP2B
NCT01994642,NCT02600559,NCT01908803,NCT02719158 |
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
ADORA2A
NCT02300220,NCT01072942,NCT00961038,NCT04879030 |
Acute pyelonephritisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB51 |
NCT01928433,NCT02598362,NCT01595438,NCT01505634,NCT01599806
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
ADORA2A,TOP2B
NCT00625183,NCT04952129 |
AnthraxDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B97 |
NCT01952444,NCT00138411,NCT01753115,NCT00964561
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
TRPA1,ADORA3,TRPA1,ADORA3
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
ADORA2A,TOP2B,ADORA3
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
ADORA2A,TOP2B
NCT00526890 |
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
ADORA3,ADORA1,ADORA2A
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
TOP2B
NCT00829205,NCT02532192 |
Cystic fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA25 |
NCT00645788,NCT02015507,NCT01768663
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT01690884,NCT03236311,NCT01593644
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
TRPA1,ADORA3,ADORA2A
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
TRPA1,TOP2B,ADORA1
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
TRPA1,ADORA3,ADORA2A
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
TRPA1,ADORA3,ADORA2A
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
TRPA1,TOP2B,ADORA2A
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
ADORA2A,ADORA1
|
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
ADORA2A,ADORA1
|
Orthostatic hypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA21 |
ADORA2A,ADORA1
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
TOP2B
NCT00670215 |
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
TOP2B
NCT00590785 |
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
ADORA3,TOP2B
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
ADORA1,ADORA2A
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
ADORA3,TOP2B
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
TOP2B
NCT00455416 |
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
TOP2B
NCT02773732 |
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
ADORA2A
NCT02036528 |
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT01561794,NCT03177720
|
Acute ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.0 |
NCT01747174,NCT00284323
|
Amyotrophic lateral sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60.0 |
NCT04090684,NCT04165850
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT01279252,NCT00714103
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT03032965,NCT01932112
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
NCT01123525,NCT00751491
|
Other specified bacterial diseasesDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C4Y |
NCT03326050,NCT05431673
|
Diseases of the digestive system, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
NCT00741052,NCT00142272
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
NCT00298636,NCT00349921
|
Stress-induced cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.5 |
NCT02867878,NCT04666454
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT00004216,NCT00845689
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT00580905,NCT01052298
|
Chronic prostatitisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA91.0 |
NCT04552431,NCT02130713
|
Clear cell renal cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH46F1 |
NCT05363631,NCT02535533
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
TRPA1,ADORA1
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
ADORA1,ADORA3
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
ADORA1,ADORA2A
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
TRPA1,ADORA1
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
TRPA1,ADORA3
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
ADORA3,ADORA2A
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
ADORA1,ADORA1
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
TRPA1,ADORA2A
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
TRPA1,ADORA3
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
TOP2B
NCT00598403,NCT00668122,NCT00669994,NCT03354598,NCT00809913,NCT03357614,NCT00663806,NCT01749605,NCT01803191,NCT00481689,NCT00722735,NCT00676533,NCT00126698 |
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NCT05442736,NCT02505581,NCT00002850,NCT02357407,NCT01757236,NCT03358576,NCT02734732,NCT01756924,NCT01789203,NCT04870138,NCT03840811,NCT03150082,NCT01659866
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
TOP2B
NCT01910155,NCT01359098,NCT02216071,NCT00961675,NCT02801370,NCT01157819,NCT02511561,NCT00945802,NCT04636957,NCT00872209,NCT00980876 |
Upper respiratory tract disorderDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0Z |
TRPA1
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
TOP2B
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
TOP2B
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
ADORA2A
|
Cardiac arrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC9Z |
ADORA1
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
TOP2B
|
Radionuclide imagingDisease Category: NADisease ICD-11 Code: N.A. |
ADORA2A
|
Supraventricular tachyarrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81 |
ADORA1
|
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
TOP2B
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
TRPA1
|
Vasomotor/allergic rhinitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA08 |
ADORA2A
|
Hepatitis virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50-1E51 |
ADORA3
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
ADORA3
|
Gonococcal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A70-1A7Z |
TOP2B
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
TOP2B
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
TOP2B
|
Common wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E80 |
TOP2B
|
Unspecific substance use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4Z |
ADORA2A
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
ADORA2A
|
ChemoprotectionDisease Category: NADisease ICD-11 Code: N.A. |
TOP2B
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
TOP2B
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
TOP2B
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
TOP2B
|
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
TOP2B
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
ADORA2A
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TOP2B
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
TOP2B
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TOP2B
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
ADORA2A
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
ADORA1
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
ADORA3
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
ADORA2A
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
TOP2B
|
Anogenital wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A95 |
TOP2B
|
SyphilisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A61-1A6Z |
TOP2B
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
TOP2B
|
Gastroenteritis or colitis without specification of originDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A40.0 |
NCT00654108
|
Gonococcal infection, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A7Z |
NCT05294588
|
Immune thrombocytopenic purpuraDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64.10 |
NCT00688272
|
DiarrhoeaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05.1 |
NCT01208922
|
Other specified infections of the nail or perionychiumDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EE12.Y |
NCT00910351
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT04523987
|
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT00003824
|
Pyogenic abscess of the skinDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B75.3 |
NCT04549311
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT05462496
|
Acute myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41 |
NCT00781404
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
NCT00179010
|
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
NCT01233492
|
Periapical periodontitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA09.7 |
NCT02947763
|
Abscess of liverDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB90.0 |
NCT03969758
|
Hearing disorderDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AB50-AB57 |
NCT01108601
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
NCT00590070
|
Ventricular tachycardiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC71.0 |
NCT04392362
|
NeutropeniaDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B00 |
NCT00107081
|
Alcoholic hepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94.1 |
NCT02326103
|
Hashimoto thyroiditisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A03.20 |
NCT02302768
|
CardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43 |
NCT02681913
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
NCT04588441
|
PlagueDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B93 |
NCT01243437
|
Alcoholic cirrhosis of liver without hepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94.3 |
NCT02326103
|
Diseases of coronary artery, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Z |
NCT00612521
|
Fever of other or unknown originDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG26 |
NCT00107081
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT01124799
|
EndophthalmitisDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C21 |
NCT05162625
|
Infection, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1H0Z |
NCT00761462
|
PeritonitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DC50 |
NCT02011841
|
Urolithiasis, unspecifiedDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB7Z |
NCT01873690
|
CataractDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B10 |
NCT04204954
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
NCT00791505
|
Malignant neoplasms of prostate, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.Z |
NCT01497431
|
Osteomyelitis or osteitisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB84 |
NCT02099240
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT01211561
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT00565188
|
Ischaemic heart diseases, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA6Z |
NCT05014061
|
BacteraemiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MA15.0 |
NCT05199324
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
ADORA2A
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
TRPA1
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
TRPA1
|
Intrauterine growth restrictionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA20.1 |
ADORA2A
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
TRPA1
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
ADORA2A
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
ADORA2A
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
TRPA1
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
ADORA2A
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
ADORA3
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
ADORA1
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TOP2B
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
TRPA1
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
ADORA2A
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
ADORA3
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
ADORA3
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
ADORA1
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
ADORA3
|